Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical Outcomes
- 26 October 2004
- journal article
- clinical trial
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 38 (12), 2023-2028
- https://doi.org/10.1345/aph.1d605
Abstract
BACKGROUND The practice of pharmaceutical care in primary care settings in Thailand is currently not generally accepted. OBJECTIVE To evaluate the effect of pharmacist involvement in treatment with hypertensive patients in primary care settings. METHODS The treatment objective was to stabilize the blood pressure (BP) of hypertensive patients in accordance with the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure guidelines. Patients were randomly assigned to a pharmacist-involved group (treatment) or a group with no pharmacist involvement (control). Pre- and post-test BPs, tablet counts, lifestyle modifications, and pharmacists’ recommendations were recorded. The 6-month study was carried out in Mahasarakham University pharmacy and 2 primary care units. Patients were monitored monthly by reviewing their medications and supported by providing pharmaceutical care and counseling. RESULTS From a total of 235 patients, the treatment group (n = 118) had a significant reduction in both systolic (S) and diastolic (D) BP compared with the 117 patients of the control group (p = 0.037, 0.027, respectively). The 158 patients (76 treatment, 82 control) with BPs 140/90 mm Hg at the beginning of the study showed significant BP reductions (p = 0.002 SBP, 0.008 DBP). The proportion of 158 patients whose BP became stabilized was higher in the treatment group (p = 0.017). The treatment group showed significantly better adherence (p = 0.014) and exercise control (p = 0.012) at the end of the study. Physicians accepted 42.72% of medication modifications and 5.34% of the suggestions for additional investigations. CONCLUSIONS Hypertensive patients who received pharmacist input achieved a significantly greater benefit in BP reduction, BP control, and improvement in adherence rate and lifestyle modification.Keywords
This publication has 15 references indexed in Scilit:
- Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsThe Lancet, 2003
- Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United StatesJama-Journal Of The American Medical Association, 2003
- Physician‐Pharmacist Comanagement of Hypertension: A Randomized, Comparative TrialPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Improving Blood Pressure Control in a Pharmacist‐Managed Hypertension ClinicPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- Evaluation of a Pharmaceutical Care Program for Hypertensive Patients in Rural PortugalJournal of the American Pharmaceutical Association, 2002
- Cardiovascular protection and blood pressure reduction: a meta-analysisThe Lancet, 2001
- Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of StrokeThe Systolic Hypertension in the Elderly Program (SHEP)Jama-Journal Of The American Medical Association, 2000
- Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trialsThe Lancet, 2000
- Control of Blood Pressure and Risk of Stroke Among Pharmacologically Treated Hypertensive PatientsStroke, 2000
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of Internal Medicine, 1997